[Insulin resistance and metabolic anomalies associated with hypertension and overweight].
作者信息
Vague P
机构信息
Service d'endocrinologie--nutrition Centre hospitalier régional et universitaire de La Timone, Marseille.
出版信息
Rev Prat. 1994 Sep 1;44(13 Suppl):46-8.
PMID:8091114
Abstract
摘要
相似文献
1
[Insulin resistance and metabolic anomalies associated with hypertension and overweight].[与高血压和超重相关的胰岛素抵抗及代谢异常]
Rev Prat. 1994 Sep 1;44(13 Suppl):46-8.
2
Hypertension, hyperlipidemia, insulin resistance and obesity: parts of a metabolic syndrome.高血压、高脂血症、胰岛素抵抗和肥胖：代谢综合征的组成部分。
Blood Press Suppl. 1992;4:49-54.
3
[Metabolic syndrome with vascular risk and arterial hypertension].[伴有血管风险和动脉高血压的代谢综合征]
Medicina (B Aires). 1996;56(2):183-94.
4
Metabolic characteristics of glucose intolerance: the critical role of obesity.葡萄糖不耐受的代谢特征：肥胖的关键作用。
Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):86-93. doi: 10.1055/s-2007-985382. Epub 2007 Oct 31.
5
[Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].[对有胰岛素抵抗临床症状且肾功能正常患者的选定炎症标志物评估]
Pol Merkur Lekarski. 2006 Aug;21(122):165-8; discussion 169.
6
Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.重度、病态和极度肥胖患者的C3水平：其与胰岛素抵抗及不同心血管危险因素的关系。
Int J Obes (Lond). 2007 Jun;31(6):927-32. doi: 10.1038/sj.ijo.0803543. Epub 2007 Feb 13.
7
Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.超重受试者的代谢风险因素以及心血管和肾脏损伤标志物
Am J Hypertens. 2006 Apr;19(4):426-31. doi: 10.1016/j.amjhyper.2005.10.002.
8
Effect of doxazosin on insulin resistance in hypertensive patients with obesity.多沙唑嗪对肥胖高血压患者胰岛素抵抗的影响。
Horm Metab Res. 2003 Sep;35(9):532-6. doi: 10.1055/s-2003-42654.
9
10
Obesity, hypertension and insulin resistance.肥胖、高血压与胰岛素抵抗。
Acta Diabetol. 2005 Apr;42 Suppl 1:S3-8. doi: 10.1007/s00592-005-0175-1.
Zotero 插件